- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
321 results
No. 24
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 24 (N.D.W.Va. Mar. 31, 2023)
|
|
Cite Document
No. 26
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 26 (N.D.W.Va. Mar. 31, 2023)
|
|
Cite Document
No. 29
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 29 (N.D.W.Va. May. 19, 2022)
|
|
Cite Document
No. 28
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 28 (N.D.W.Va. May. 19, 2022)
|
|
Cite Document
No. 23
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23 (N.D.W.Va. May. 9, 2022)
|
|
Cite Document
No. 15
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 15 (N.D.W.Va. Feb. 8, 2023)
|
|
Cite Document
No. 21
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 21 (N.D.W.Va. Apr. 29, 2022)
|
|
Cite Document
No. 5
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 5 (N.D.W.Va. Jan. 30, 2023)
|
|
Cite Document
No. 4
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 4 (N.D.W.Va. Jan. 30, 2023)
|
|
Cite Document
No. 3
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 3 (N.D.W.Va. Jan. 27, 2023)
|
|
Cite Document
No. 2
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 2 (N.D.W.Va. Jan. 27, 2023)
|
|
Cite Document
No. 19
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 19 (N.D.W.Va. Apr. 8, 2022)
|
|
Cite Document
No. 12
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 10
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 9
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
